These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1906828)

  • 41. Studies on the mechanisms of 6-hydroxydopamine cytotoxicity.
    Jonsson G
    Med Biol; 1976 Dec; 54(6):406-20. PubMed ID: 1034180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of 6-hydroxydopamine oxidation by various proteins.
    Padiglia A; Medda R; Lorrai A; Biggio G; Sanna E; Floris G
    Biochem Pharmacol; 1997 Apr; 53(8):1065-8. PubMed ID: 9175710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease.
    Jellinger K; Linert L; Kienzl E; Herlinger E; Youdim MB
    J Neural Transm Suppl; 1995; 46():297-314. PubMed ID: 8821067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase.
    Segura-Aguilar J; Lind C
    Chem Biol Interact; 1989; 72(3):309-24. PubMed ID: 2557982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation by 6-hydroxydopamine of the cerebral factor(s) responsible for the inhibition of the autoxidation of norepinephrine in vitro.
    Kovachich GB
    Neurosci Lett; 1985 Jul; 58(2):245-50. PubMed ID: 3931006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is the autoxidation of catecholamines involved in ischemia-reperfusion injury?
    Jewett SL; Eddy LJ; Hochstein P
    Free Radic Biol Med; 1989; 6(2):185-8. PubMed ID: 2496008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of superoxide dismutase and catalase to protect catecholamines from oxidation in tissue culture studies.
    Mahan LC; Insel PA
    Anal Biochem; 1984 Jan; 136(1):208-16. PubMed ID: 6711809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of the neurotoxin 6-hydroxydopamine by peroxidase/H2O2 oxidation of dopamine.
    Napolitano A; Crescenzi O; Pezzella A; Prota G
    J Med Chem; 1995 Mar; 38(6):917-22. PubMed ID: 7699708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxic effects of 6-hydroxydopamine, merocyanine-540 and related compounds on human neuroblastoma and hematopoietic stem cells.
    Bruchelt G; Grygar G; Treuner J; Esterbauer H; Niethammer D
    Free Radic Res Commun; 1989; 7(3-6):205-12. PubMed ID: 2511086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease.
    Soto-Otero R; Méndez-Alvarez E; Hermida-Ameijeiras A; Muñoz-Patiño AM; Labandeira-Garcia JL
    J Neurochem; 2000 Apr; 74(4):1605-12. PubMed ID: 10737618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjunctive treatment of murine neuroblastoma with 6-hydroxydopamine and Tempol.
    Purpura P; Westman L; Will P; Eidelman A; Kagan VE; Osipov AN; Schor NF
    Cancer Res; 1996 May; 56(10):2336-42. PubMed ID: 8625308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.
    Robinson TE; Whishaw IQ
    Brain Res; 1988 May; 450(1-2):209-24. PubMed ID: 3135914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iron accelerates the conversion of dopamine-oxidized intermediates into melanin and provides protection in SH-SY5Y cells.
    Izumi Y; Sawada H; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
    J Neurosci Res; 2005 Oct; 82(1):126-37. PubMed ID: 16108071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro.
    Mazzio EA; Reams RR; Soliman KF
    Brain Res; 2004 Apr; 1004(1-2):29-44. PubMed ID: 15033417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible involvement of catalase in the protective effect of interleukin-6 against 6-hydroxydopamine toxicity in PC12 cells.
    Yamada K; Umegaki H; Maezawa I; Iguchi A; Kameyama T; Nabeshima T
    Brain Res Bull; 1997; 43(6):573-7. PubMed ID: 9254029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amine-mediated toxicity. The effects of dopamine, norepinephrine, 5-hydroxytryptamine, 6-hydroxydopamine, ascorbate, glutathione and peroxide on the in vitro activities of creatine and adenylate kinases in the brain of the rat.
    Maker HS; Weiss C; Brannan TS
    Neuropharmacology; 1986 Jan; 25(1):25-32. PubMed ID: 3005902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Youdim MB; Stephenson G; Ben Shachar D
    Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant.
    Reynolds CP; Reynolds DA; Frenkel EP; Smith RG
    Cancer Res; 1982 Apr; 42(4):1331-6. PubMed ID: 7037175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The dopamine-depleting effect of 6-hydroxydopamine does not increase with aging.
    Ricaurte GA; DeLanney LE; Finnegan KT; Irwin I; Langston JW
    Brain Res; 1988 Jan; 438(1-2):395-8. PubMed ID: 3125947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.